Illustrative

Insilico Medicine announces developmental candidate benchmarks and timelines for novel therapeutics discovered using generative AI

EurekAlert!·Feb 11

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Insilico Medicine has announced benchmarks and timelines for developmental candidates. These candidates are for novel therapeutics that were discovered using generative AI. The company has shared its plans for the development of these therapeutics.

Full coverage

Generative AI Leap: Insilico Medicine Nominates First Preclinical Candidate in the UAE

Insilico Medicine·Apr 23

Transforming Parkinson’s disease treatment, Insilico Medicine announces IND-enabling completion for AI-empowered oral NLRP3 inhibitor ISM8969

Insilico Medicine·Aug 14

Insilico Medicine named a 2025 BostInno Fire Awards honoree

Insilico Medicine·Oct 29

Transforming Drug Target Discovery, Insilico Medicine Publishes Landmark Paper Introducing AI-empowered Target Identification Pro (TargetPro) and TargetBench 1.0

Insilico Medicine·Oct 4

Insilico Medicine provides benchmark timelines from its 22 AI-designed drug candidates

Fierce Biotech·Feb 11

From Start to Phase 1 in 30 Months

Insilico Medicine·Mar 17

In-silico Drug Discovery Market Size to Hit USD 11.8 Billion by 2035

Precedence Research·Oct 22

View original report at EurekAlert! ↗

Fetching the latest headlines…